The groundbreaking therapy of this peptide represents a exciting advance in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment